Bank Of New York Mellon Corp Amneal Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.27 - $2.7 $588,265 - $1.25 Million	463,201 New	463,201 $644 Million
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $955,231 - $1.27 Million	487,363 New	487,363 $969,000
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $98,022 - $175,664	48,526 Added 9.0%	587,856 $1.19 Million
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $81,291 - $120,451	-27,007 Reduced 4.77%	539,330 $1.72 Million
Q1 2022 May 11, 2022	BUY	$3.9 - $4.89 $23,778 - $29,814	6,097 Added 1.09%	566,337 $2.36 Million
Q4 2021 Feb 11, 2022	SELL	$3.95 - $5.85 $97,181 - $143,927	-24,603 Reduced 4.21%	560,240 $2.68 Million
Q3 2021 Nov 12, 2021	BUY	$4.31 - $5.64 $134,019 - $175,375	31,095 Added 5.62%	584,843 $3.12 Million
Q2 2021 Aug 11, 2021	SELL	$5.12 - $6.82 $439,270 - $585,121	-85,795 Reduced 13.42%	553,748 $2.84 Million
Q1 2021 May 13, 2021	SELL	$4.74 - $7.38 $641,212 - $998,344	-135,277 Reduced 17.46%	639,543 $4.3 Million
Q4 2020 Feb 09, 2021	SELL	$3.95 - $5.42 $881,742 - $1.21 Million	-223,226 Reduced 22.37%	774,820 $3.54 Million
Q3 2020 Nov 12, 2020	SELL	$3.54 - $5.27 $193,730 - $288,406	-54,726 Reduced 5.2%	998,046 $3.87 Million
Q2 2020 Aug 12, 2020	SELL	$2.87 - $5.46 $574,680 - $1.09 Million	-200,237 Reduced 15.98%	1,052,772 $5.01 Million
Q1 2020 May 06, 2020	SELL	$2.46 - $5.35 $170,741 - $371,327	-69,407 Reduced 5.25%	1,253,009 $4.36 Million
Q4 2019 Feb 14, 2020	BUY	$2.65 - $5.56 $2.09 Million - $4.38 Million	787,166 Added 147.07%	1,322,416 $6.37 Million
Q3 2019 Nov 07, 2019	BUY	$2.29 - $7.1 $77,498 - $240,278	33,842 Added 6.75%	535,250 $1.55 Million
Q2 2019 Aug 12, 2019	BUY	$6.44 - $14.29 $99,401 - $220,566	15,435 Added 3.18%	501,408 $3.6 Million
Q1 2019 May 14, 2019	BUY	$11.87 - $14.84 $536,215 - $670,382	45,174 Added 10.25%	485,973 $6.89 Million
Q4 2018 Feb 11, 2019	SELL	$13.09 - $21.49 $703,404 - $1.15 Million	-53,736 Reduced 10.87%	440,799 $5.96 Million
Q3 2018 Nov 09, 2018	BUY	$16.4 - $24.27 $446,178 - $660,289	27,206 Added 5.82%	494,535 $0
Q2 2018 Aug 06, 2018	BUY	$13.95 - $20.2 $6.52 Million - $9.44 Million	467,329 New	467,329 $7.67 Million

Others Institutions Holding AMRX

# of Institutions

185

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.25B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account